Dan Glaser and Michelle Seitz were elected to MetLife’s Board of Directors (Board), effective immediately. Both leaders bring significant leadership and business experience to their roles, the company announced.

According to the press release, Glaser, currently an operating partner at the private investment firm CD&R, has held senior positions in commercial insurance and insurance brokerage for more than 40 years, including serving for a decade as president and CEO of Marsh McLennan (MMC). He was also president and chief operating officer of Willis Risk Solutions and held senior roles at AIG, including leading its U.K. and Ireland operations. For 10 years, Glaser served as chairman of the U.S. Federal Advisory Committee on Insurance.

Seitz brings more than 30 years of investment management experience to the Board, most recently serving as chair and CEO of Russell Investments and CEO of investment bank, William Blair, before that. She is the founder and CEO of MeydenVest Partners LLC, a strategic advisory firm providing capital and counsel to high potential companies. Seitz also currently serves as an independent director of MSCI Inc. and Sana Biotechnology, Inc.

“We are pleased to welcome Michelle and Dan to MetLife’s Board of Directors”, said R. Glenn Hubbard, chairman of MetLife. “Together, they bring deep leadership experience and industry expertise that will further enable MetLife to deliver for its shareholders and all stakeholders”, the chairman added.

“Michelle and Dan embody the kind of strategic leadership, global perspective, and established expertise that will help guide MetLife in our New Frontier strategy”, commented Michel Khalaf, MetLife President and CEO. “Dan’s decades of experience shaping the insurance industry and Michelle’s proven track record in investment management make them exceptional additions to our Board”, Michel Khalaf concluded.